Detecting Early Myocardial Infiltration w/Amyloid & Light Chain Deposition Disease in Multiple Myeloma Subjects
NCT ID: NCT01018927
Last Updated: 2017-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
44 participants
OBSERVATIONAL
2009-06-30
2017-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Native T1 CMR Imaging for Diagnosis of Cardiac Amyloidosis
NCT04862273
The Diagnostic Pattern and Prognosis of Multiple Myeloma Patients With Myocardial Amyloidosis Were Evaluated by NMR Based Metabolomics
NCT05718401
Prospective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging
NCT02462213
Cardiac Fibrosis by CMR in Patients With Cancer
NCT01906437
Molecular Imaging of Primary Amyloid Cardiomyopathy
NCT02641145
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Additional MRI images
Prospective review of 100 CMR studies performed on multiple myeloma patients referred for cardiac evaluation by MRI. Three additional MRI images will be performed to determine the role of cardiac MR (CMR) in detecting features of early myocardial infiltration
Administering three additional MRI images
Three additional MRI images to determine the role of cardiac MR (CMR) in detecting features of early myocardial infiltration
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Administering three additional MRI images
Three additional MRI images to determine the role of cardiac MR (CMR) in detecting features of early myocardial infiltration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male and female ages 18-80 years of age
* History of multiple myeloma
* CMR study for evaluation for cardiac amyloidosis
Exclusion Criteria
* Subject with a metallic or electronic or other device that could be affected by the magnet
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Siemens Molecular Imaging
INDUSTRY
University of Arkansas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tarun Pandey
Role: PRINCIPAL_INVESTIGATOR
University of Arkansas for Medical Sciences (UAMS)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University or Arkansas for Medical Sciences (UAMS)
Little Rock, Arkansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
110104
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.